Persistent Corneal Epithelial Defects

Also known as: Corneal Persistent Epithelial Defect / Persistent Corneal Epithelial Defect / Persistent corneal epithelial defect (disorder)

Drug	Drug Name	Drug Description
DB13926	Cenegermin	A recombinant human nerve growth factor used to treat neurotrophic keratitis.

Drug	Drug Name	Target	Type
DB13926	Cenegermin	High affinity nerve growth factor receptor	target
DB13926	Cenegermin	Tumor necrosis factor receptor superfamily member 16	target

Drug	Drug Name	Phase	Status	Count
DB15869	Platelet Lysate	1 / 2	Completed	1
DB14915	CODA-001	2	Recruiting	1
DB14915	CODA-001	2	Terminated	1
DB08818	Hyaluronic acid	2	Completed	1
DB11252	Poloxamer 407	2	Terminated	1
DB18614	ST266	2	Completed	1
DB18614	ST266	2	Terminated	1
DB08823	Spinosad	2	Completed	1
DB14915	CODA-001	2 / 3	Recruiting	1